Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Human Granulocyte Colony-Stimulating market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Human Granulocyte Colony-Stimulatingmarket, defines the market attractiveness level of Recombinant Human Granulocyte Colony-Stimulating market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Human Granulocyte Colony-Stimulating industry, describes the types of Recombinant Human Granulocyte Colony-Stimulating market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Human Granulocyte Colony-Stimulating market and the development prospects and opportunities of Recombinant Human Granulocyte Colony-Stimulating industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Human Granulocyte Colony-Stimulating market in Chapter 13.
By Player:
Huaxin
Triprime
Kawin
Amgen
Gensci
Qilu Pharmaceutical
Sinovac
Kyowa Hakko Kirin
Amoytop Biotech
Shijiazhuang Pharmaceutical
Zhaoke
Hangzhou Jiuyuan
By Type:
Lenograstim (Granocyte)
Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
Others
By End-User:
Chemotherapy Induced Neutropenia
Before Blood Donation
Stem Cell Transplants
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Human Granulocyte Colony-Stimulating Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Human Granulocyte Colony-Stimulating Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Human Granulocyte Colony-Stimulating Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Human Granulocyte Colony-Stimulating Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.2 United States Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.4 China Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.5 Japan Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.6 India Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
-
7.7 South Korea Recombinant Human Granulocyte Colony-Stimulating Consumption (2017-2022)
8 Region and Country-wise Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.4 China Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.6 India Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast (2022-2028)
9 Global Recombinant Human Granulocyte Colony-Stimulating Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lenograstim (Granocyte) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chemotherapy Induced Neutropenia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Before Blood Donation Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Stem Cell Transplants Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Recombinant Human Granulocyte Colony-Stimulating Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lenograstim (Granocyte) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chemotherapy Induced Neutropenia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Before Blood Donation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Stem Cell Transplants Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Human Granulocyte Colony-Stimulating Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Human Granulocyte Colony-Stimulating Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Human Granulocyte Colony-Stimulating Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Human Granulocyte Colony-Stimulating Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Human Granulocyte Colony-Stimulating Market Competitive Analysis
-
14.1 Huaxin
-
14.1.1 Huaxin Company Details
-
14.1.2 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.2 Triprime
-
14.2.1 Triprime Company Details
-
14.2.2 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.3 Kawin
-
14.3.1 Kawin Company Details
-
14.3.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.5 Gensci
-
14.5.1 Gensci Company Details
-
14.5.2 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.6 Qilu Pharmaceutical
-
14.6.1 Qilu Pharmaceutical Company Details
-
14.6.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.7 Sinovac
-
14.7.1 Sinovac Company Details
-
14.7.2 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.8 Kyowa Hakko Kirin
-
14.8.1 Kyowa Hakko Kirin Company Details
-
14.8.2 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.9 Amoytop Biotech
-
14.9.1 Amoytop Biotech Company Details
-
14.9.2 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.10 Shijiazhuang Pharmaceutical
-
14.10.1 Shijiazhuang Pharmaceutical Company Details
-
14.10.2 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.11 Zhaoke
-
14.11.1 Zhaoke Company Details
-
14.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
14.12 Hangzhou Jiuyuan
-
14.12.1 Hangzhou Jiuyuan Company Details
-
14.12.2 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Human Granulocyte Colony-Stimulating
-
Figure Recombinant Human Granulocyte Colony-Stimulating Picture
-
Table Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Human Granulocyte Colony-Stimulating Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Human Granulocyte Colony-Stimulating Consumption by Country (2017-2022)
-
Figure United States Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lenograstim (Granocyte) Consumption and Growth Rate (2017-2022)
-
Figure Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Induced Neutropenia Consumption and Growth Rate (2017-2022)
-
Figure Global Before Blood Donation Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplants Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lenograstim (Granocyte) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Induced Neutropenia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Before Blood Donation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Human Granulocyte Colony-Stimulating Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Human Granulocyte Colony-Stimulating Export by Region (Top 5 Countries) (2017-2028)
-
Table Huaxin (Foundation Year, Company Profile and etc.)
-
Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Triprime (Foundation Year, Company Profile and etc.)
-
Table Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Triprime Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Kawin (Foundation Year, Company Profile and etc.)
-
Table Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kawin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Gensci (Foundation Year, Company Profile and etc.)
-
Table Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gensci Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Sinovac (Foundation Year, Company Profile and etc.)
-
Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Amoytop Biotech (Foundation Year, Company Profile and etc.)
-
Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Shijiazhuang Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Zhaoke (Foundation Year, Company Profile and etc.)
-
Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
Table Hangzhou Jiuyuan (Foundation Year, Company Profile and etc.)
-
Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product and Service
-
